Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-425
Closed -$202K 820
2021
Q2
$202K Sell
425
-650
-60% -$312K ﹤0.01% 746
2021
Q1
$494K Buy
1,075
+38
+4% +$18.6K 0.01% 531
2020
Q4
$552K Buy
1,037
+154
+17% +$75.7K 0.01% 483
2020
Q3
$424K Sell
883
-92
-9% -$45.1K 0.01% 501
2020
Q2
$440K Sell
975
-205
-17% -$91.5K 0.01% 478
2020
Q1
$511K Buy
+1,180
New +$527K 0.02% 449

Other funds holding CHE

Colony Group's CHE Position: Q3 2021 in Review

Colony Group sold out of Chemed (CHE) in Q3 2021, closing a stake of 425 shares — an estimated $202K sold.

Colony Group first reported a position in CHE in Q1 2020 and held it in 6 quarters. The position peaked at $552K in Q4 2020. 403 funds tracked by Wall St. Rank hold CHE as of Q3 2021.

  • Colony Group reported no remaining Chemed position as of Q3 2021 after selling out during the quarter.
  • Colony Group sold 425 Chemed shares in Q3 2021, an estimated $202K.
  • Colony Group first reported a position in Chemed in Q1 2020 and held it in 6 quarters.
  • Colony Group's Chemed position peaked at $552K in Q4 2020.
  • 403 funds tracked by Wall St. Rank held Chemed as of Q3 2021.

Based on Colony Group's 13F filing for Q3 2021, filed 17 Nov 2021.